MedPath

Polygen Pharmaceuticals Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

FDA:8

Drug Approvals

Darifenacin

Approval Date
Dec 1, 2022
FDA

memantine hydrochloride

Approval Date
Dec 1, 2022
FDA

amlodipine besylate

Approval Date
Nov 29, 2022
FDA

clopidogrel

Approval Date
Jul 28, 2022
FDA

Phentermine hydrochloride

Approval Date
Oct 22, 2020
FDA

Tramadol Hydrochloride

Approval Date
Oct 18, 2019
FDA

NAPROXEN

Approval Date
Jun 28, 2013
FDA

Ibuprofen

Approval Date
Nov 22, 2011
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.